A Case to Support the Continued Use of Rifampin in Clinical Drug–Drug Interaction Studies -Pub

A Case to Support the Continued Use of Rifampin in Clinical Drug–Drug Interaction Studies

Bercu et al. @jbercu
https://doi.org/10.1002/cpt.3256

2 Likes